Beacon Equity issues Technical Trading Overview for VeriChip Corp.
The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
(EMAILWIRE.COM, September 23, 2009 ) DALLAS, Texas - BeaconEquity.com announces an investment report featuring technology company VeriChip Corp. (NASDAQ: CHIP).
The investment report on VeriChip Corp. (NASDAQ: CHIP) should be of particular interest to other technology companies: AXCESS International Inc. (OTCBB: AXSI), Checkpoint Systems Inc. (NYSE: CKP) and I.D. Systems Inc. (Nasdaq: IDSY).
It is available at: http://www.beaconequity.com/i/CHIP
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
VeriChip Corp. (CHIP) engages in the development of human-implantable RFID microchip technology for patient identification. The Company's product is the world's first and only human-implantable RFID (radio frequency identification) microchip cleared by the Food and Drug Administration (FDA).
In the report, the analyst notes:
“On June 11, 2009, the WHO raised the threat of the H1N1 to phase 6, a pandemic alert of the highest level. The last time a pandemic outbreak of this severity occurred was in 1968, when the Hong Kong flu caused the death of more than 1 million individuals worldwide. According to the WHO, phase 4 though phase 6 alerts include recommendations to mitigate the spread of the H1N1.
“CHIP is positioned to address some of the challenges and concerns surrounding the spread of the virus; CHIP’s implantable RFID chips and patent licenses will be combined with Receptors LLC's biosensors to develop a virus triage detection system. The triage system is expected to provide information identifying whether there is a virus present; classify the virus as a pandemic threat, or not; and identify the pathogen, according to the CHIP white paper of May 7, 2009.”
To read the entire report visit: http://www.beaconequity.com/i/CHIP
See what investors are saying about these stocks at: http://www.stockhideout.com/
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
The investment report on VeriChip Corp. (NASDAQ: CHIP) should be of particular interest to other technology companies: AXCESS International Inc. (OTCBB: AXSI), Checkpoint Systems Inc. (NYSE: CKP) and I.D. Systems Inc. (Nasdaq: IDSY).
It is available at: http://www.beaconequity.com/i/CHIP
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
VeriChip Corp. (CHIP) engages in the development of human-implantable RFID microchip technology for patient identification. The Company's product is the world's first and only human-implantable RFID (radio frequency identification) microchip cleared by the Food and Drug Administration (FDA).
In the report, the analyst notes:
“On June 11, 2009, the WHO raised the threat of the H1N1 to phase 6, a pandemic alert of the highest level. The last time a pandemic outbreak of this severity occurred was in 1968, when the Hong Kong flu caused the death of more than 1 million individuals worldwide. According to the WHO, phase 4 though phase 6 alerts include recommendations to mitigate the spread of the H1N1.
“CHIP is positioned to address some of the challenges and concerns surrounding the spread of the virus; CHIP’s implantable RFID chips and patent licenses will be combined with Receptors LLC's biosensors to develop a virus triage detection system. The triage system is expected to provide information identifying whether there is a virus present; classify the virus as a pandemic threat, or not; and identify the pathogen, according to the CHIP white paper of May 7, 2009.”
To read the entire report visit: http://www.beaconequity.com/i/CHIP
See what investors are saying about these stocks at: http://www.stockhideout.com/
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Contact Information:
Beacon Equity
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Beacon Equity
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |